NOMAD POWER SOLUTIONS, INC. Operating Lease Liability
NOMAD POWER SOLUTIONS, INC. (NMAD) had Operating Lease Liability of $1.10 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability $1.10M.
- 2026-03-31: Operating Lease, Liability $1.06M.
- 2025-12-31: Operating Lease, Liability $1.03M.
- 2025-11-21: Operating Lease, Liability $1.04M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $1.10M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.06M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.03M 10-Q · filed 2026-08-14 |
| 2025-11-21 | $1.04M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |